BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20844562)

  • 1. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
    Costa ES; Pedreira CE; Barrena S; Lecrevisse Q; Flores J; Quijano S; Almeida J; del Carmen García-Macias M; Bottcher S; Van Dongen JJ; Orfao A
    Leukemia; 2010 Nov; 24(11):1927-33. PubMed ID: 20844562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
    Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
    Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.
    Hoeller S; Zhou Y; Kanagal-Shamanna R; Xu-Monette ZY; Hoehn D; Bihl M; Swerdlow SH; Rosenwald A; Ott G; Said J; Dunphy CH; Bueso-Ramos CE; Lin P; Wang M; Miranda RN; Tzankov A; Medeiros LJ; Young KH
    Hum Pathol; 2013 Jan; 44(1):110-21. PubMed ID: 22944294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
    Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
    Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma.
    Kilo MN; Dorfman DM
    Am J Clin Pathol; 1996 Apr; 105(4):451-7. PubMed ID: 8604687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
    Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
    Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
    Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
    Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunophenotypic and molecular diagnosis of composite hairy cell leukaemia and chronic lymphocytic leukaemia.
    Liptrot S; O' Brien D; Langabeer SE; Quinn F; Mackarel AJ; Elder P; Vandenberghe E; Hayden PJ
    Med Oncol; 2013 Dec; 30(4):692. PubMed ID: 23979856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
    Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.
    Auat M; Cardoso CC; Santos-Pirath IM; Rudolf-Oliveira RCM; Matiollo C; Lange BG; da Silva JP; Dametto GC; Pirolli MM; Colombo MDHP; Santos-Silva MC
    Cytometry B Clin Cytom; 2018 Jul; 94(4):588-595. PubMed ID: 29476700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
    Karube K; Scarfò L; Campo E; Ghia P
    Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.